WASHINGTON — Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly to oversee molecule discovery and infectious diseases — a move likely to rile up critics of the revolving door between FDA and industry.
Marks confirmed his new role at Lilly Research Laboratories to STAT. His first day was Monday.
“I am excited about the potential to help benefit people by advancing the development of vaccines for public health,” Marks told STAT.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
